[1]
|
Gao, Y., Reig, B., Heacock, L., Bennett, D.L., Heller, S.L. and Moy, L. (2021) Magnetic Resonance Imaging in Screen-ing of Breast Cancer. Radiologic Clinics of North America, 59, 85-98. https://doi.org/10.1016/j.rcl.2020.09.004
|
[2]
|
张艳秀, 刘永保. 全数字化乳腺摄影应用体会[J]. 齐齐哈尔医学院学报, 2012, 33(24): 3396-3398.
|
[3]
|
Liao, G.J., Henze Bancroft, L.C., Strigel, R.M., Chitalia, R.D., Kontos, D., Moy, L., et al. (2020) Background Parenchymal Enhancement on Breast MRI: A Comprehensive Review. Journal of Magnetic Resonance Imaging, 51, 43-61.
https://doi.org/10.1002/jmri.26762
|
[4]
|
Fischmann, A., Siegmann, K.C., Wersebe, A., Claussen, C.D. and Mül-ler-Schimpfle, M. (2005) Comparison of Full-Field Digital Mammography and Film-Screen Mammography: Image Quality and Lesion Detection. British Journal of Radiology, 78, 312-317. https://doi.org/10.1259/bjr/33317317
|
[5]
|
Hu, X., Jiang, L., You, C. and Gu, Y. (2021) Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates with Breast Cancer. Frontiers in Oncology, 11, Article ID: 616716.
https://doi.org/10.3389/fonc.2021.616716
|
[6]
|
Park, S.Y., Kang, D.K. and Kim, T.H. (2015) Does Background Parenchymal Enhancement on MRI Affect the Rate of Positive Resection Margin in Breast Cancer Patients. The British Journal of Radiology, 88, Article ID: 20140638.
https://doi.org/10.1259/bjr.20140638
|
[7]
|
McGuire, A., Brown, J.A. and Kerin, M.J. (2015) Metastatic Breast Cancer: The Potential of miRNA for Diagnosis and Treatment Monitoring. Cancer and Metastasis Reviews, 34, 145-155. https://doi.org/10.1007/s10555-015-9551-7
|
[8]
|
Julka, P.K., Chacko, R.T., Nag, S., Parshad, R., Nair, A., Oh, D.S., et al. (2008) A Phase II Study of Sequential Neoadjuvant Gemcitabine Plus Doxorubicin Followed by Gemcitabine Plus Cisplatin in Patients with Operable Breast Cancer: Prediction of Response Using Molecular Profiling. British Jour-nal of Cancer, 98, 1327-1335.
https://doi.org/10.1038/sj.bjc.6604322
|
[9]
|
Eby, P.R., Partridge, S.C., White, S.W., Doot, R.K., Dunnwald, L.K., Schubert, E.K., et al. (2008) Metabolic and Vascular Features of Dynamic Contrast-Enhanced Breast Magnetic Reso-nance Imaging and (15)O-Water Positron Emission Tomography Blood Flow in Breast Cancer. Academic Radiology, 15, 1246-1254.
https://doi.org/10.1016/j.acra.2008.03.019
|
[10]
|
Pike, M.C. and Pearce, C.L. (2013) Mammographic Density, MRI Background Parenchymal Enhancement and Cancer Risk. Annals of Oncology, 8, viii37-viii41. https://doi.org/10.1093/annonc/mdt310
|
[11]
|
Kim, J.Y., Kim, S.H., Kim, Y.J., Kang, B.J., An, Y.Y., Lee, A.W., Song, B.J., Park, Y.S. and Lee, H.B. (2015) Enhancement Parameters on Dynamic Contrast Enhanced Breast MRI: Do They Correlate with Prognostic Factors and Subtypes of Breast Cancers? Magnetic Resonance Imaging, 33, 72-80. https://doi.org/10.1016/j.mri.2014.08.034
|
[12]
|
Boisserie-Lacroix, M., Macgrogan, G., Debled, M., Ferron, S., Asad-Syed, M., McKelvie-Sebileau, P., et al. (2013) Triple-Negative Breast Cancers: Associations Between Imaging and Pathological Findings for Triple-Negative Tumors Compared with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Breast Cancers. The Oncologist, 18, 802-811. https://doi.org/10.1634/theoncologist.2013-0380
|
[13]
|
Baek, J.E., Kim, S.H. and Lee, A.W. (2014) Background Parenchymal Enhancement in Breast MRIs of Breast Cancer Patients: Impact on Tumor Size Estimation. European Journal of Radiology, 83, 1356-1362.
https://doi.org/10.1016/j.ejrad.2014.05.007
|
[14]
|
Kim, S.A., Cho, N., Ryu, E.B., Yun, B.L., Bae, M.S., Chie, E.K., et al. (2013) Predicting Local Recurrence Following Breast-Conserving Treatment: Parenchymal Signal Enhancement Ra-tio (SER) around the Tumor on Preoperative MRI. Acta Radiologica, 54, 731-738. https://doi.org/10.1177/0284185113483676
|
[15]
|
Kim, S.A., Cho, N., Ryu, E.B., Seo, M., Bae, M.S., Chang, J.M., et al. (2014) Background Parenchymal Signal Enhancement Ratio at Preoperative MR Imaging: Association with Subse-quent Local Recurrence in Patients with Dctal Carcinoma in Situ after Breast Conservation Surgery. Radiology, 270, 699-707.
https://doi.org/10.1148/radiol.13130459
|
[16]
|
Witteveen, A., Vliegen, I.M., Sonke, G.S., Klaase, J.M., IJzerman, M.J. and Siesling, S. (2015) Personalisation of Breast Cancer Follow-Up: A Time-Dependent Prognostic Nomogram for the Estimation of Annual Risk of Locoregional Recurrence in Early Breast Cancer Patients. Breast Cancer Research and Treatment, 152, 627-636.
https://doi.org/10.1007/s10549-015-3490-4
|
[17]
|
Ishitobi, M., Shiba, M., Nakayama, T., Koyama, H. and Tamaki, Y. (2015) Association of Human Epidermal Growth Factor Receptor 2 Status with Ipsilateral Breast Tumor Recurrence and Resistance to Endocrine Therapy. Molecular and Clinical Oncology, 3, 843-846. https://doi.org/10.3892/mco.2015.534
|
[18]
|
Zhang, C., Wang, S., Israel, H.P., Yan, S.X., Horowitz, D.P., Crock-ford, S., et al. (2015) Higher Locoregional Recurrence Rate for Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy, Surgery and Radiotherapy. SpringerPlus, 30, Article No. 386. https://doi.org/10.1186/s40064-015-1116-2
|
[19]
|
Lo Gullo, R., Daimiel, I., Rossi Saccarelli, C., Bitencourt, A., Se-vilimedu, V., Martinez, D.F., et al. (2020) MRI Background Parenchymal Enhancement, Fibroglandular Tissue, and Mammographic Breast Density in Patients with Invasive Lobular Breast Cancer on Adjuvant Endocrine Hormonal Treatment: Associations with Survival. Breast Cancer Research, 22, Article No. 93. https://doi.org/10.1186/s13058-020-01329-z
|
[20]
|
Zhang, M., Sadinski, M., Haddad, D., Bae, M.S., Martinez, D., Morris, E.A., et al. (2020) Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation with Breast Cancer Oncotype Dx Score. Frontiers in Oncology, 10, Article ID: 595820. https://doi.org/10.3389/fonc.2020.595820
|
[21]
|
Moliere, S., Oddou, I., Noblet, V., Veillon, F. and Mathelin, C. (2019) Quantitative Background Parenchymal Enhancement to Predict Recurrence after Neoadjuvant Chemotherapy for Breast Cancer. Scientific Reports, 9, Article No. 19185. https://doi.org/10.1038/s41598-019-55820-5
|
[22]
|
Park, S., Han, W., Kim, J., Kim, M.K., Lee, E., Yoo, T.K., et al. (2015) Risk Factors Associated with Distant Metastasis and Sur-vival Outcomes in Breast Cancer Patients with Locoregional Recurrence. Journal Breast Cancer, 18, 160-166. https://doi.org/10.4048/jbc.2015.18.2.160
|